TY - JOUR AV - public A1 - Malik, Farihah A1 - Crichton, Siobhan A1 - Plotnikova, Yulia A1 - Latysheva, Inga A1 - Samarina, Anna A1 - Pokorska-?piewak, Maria A1 - Gomez, Marisa Navarro A1 - Bailey, Heather A1 - Thorne, Claire A1 - Judd, Ali A1 - Turkova, Anna A1 - Collins, Intira Jeannie SN - 0891-3668 N2 - We evaluated the effectiveness and safety of direct-acting antivirals in adolescents with hepatitis C (HCV)/HIV coinfection using pooled individual patient-level data from 5 European cohorts. Of 122 participants in follow-up from November 2013 to August 2021, 19 were treated <18 years of age; of 15 with HCV RNA available at/after 12 weeks post-treatment, all had sustained virologic response with acceptable safety. This evidence addresses an important gap in knowledge of treatment outcomes in adolescents with HCV/HIV coinfection in real-life settings. KW - Hepatitis C KW - HIV KW - treatment KW - adolescents KW - pediatric KW - directacting antivirals JF - The Pediatric Infectious Disease Journal PB - Ovid Technologies (Wolters Kluwer Health) ID - discovery10186762 Y1 - 2024/02/02/ UR - http://dx.doi.org/10.1097/inf.0000000000004271 TI - Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe N1 - © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBYNC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. ER -